Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | STK10 | O94804 | 2/20 | 0.44 |
| ▸ | SLK | Q9H2G2 | 2/20 | 0.44 |
| ▸ | PDK2 | Q15119 | 3/20 | 0.43 |
| ▸ | PARP1 | P09874 | 1/20 | 0.43 |
| ▸ | SCN9A | Q15858 | 5/20 | 0.42 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.40 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.40 |
| ▸ | MEN1 | O00255 | 1/20 | 0.40 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.40 |
| ▸ | MAPT | P10636 | 1/20 | 0.40 |
| ▸ | PKM | P14618 | 1/20 | 0.40 |
| ▸ | HPGD | P15428 | 1/20 | 0.40 |
| ▸ | HTT | P42858 | 1/20 | 0.40 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.40 |
| ▸ | SCN10A | Q9Y5Y9 | 1/20 | 0.40 |
| ▸ | STK39 | Q9UEW8 | 2/20 | 0.39 |
| ▸ | ATM | Q13315 | 1/20 | 0.39 |
| ▸ | THRA | P10827 | 1/20 | 0.38 |
| ▸ | THRB | P10828 | 1/20 | 0.38 |
| ▸ | MAPK8 | P45983 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL16704113 | 0.82 | PDK2 (0.43) | STK10SLKPDK2PARP1SCN9A | |
| SCHEMBL28916377 | 0.81 | BCAT2 (0.42) | PDK2SCN9AKMT2AKDM4EMEN1 | |
| SCHEMBL16704104 | 0.80 | SCN9A (0.41) | STK10SLKPDK2PARP1SCN9A | |
| SCHEMBL16704020 | 0.78 | NPC1 (0.47) | PDK2PARP1SCN9AALDH1A1HPGD | |
| SCHEMBL16704193 | 0.76 | PARP1 (0.39) | PDK2PARP1SCN9ASCN10AMAPK8 | |
| SCHEMBL25436660 | 0.74 | KDM4E (0.44) | PDK2KMT2AKDM4EMEN1ALDH1A1 | |
| SCHEMBL27600108 | 0.74 | PDK2 (0.41) | PDK2SCN9AKMT2AKDM4EMEN1 | |
| SCHEMBL30608075 | 0.73 | PARP1 (0.56) | PDK2PARP1SCN9AKDM4EALDH1A1 | |
| SCHEMBL5143960 | 0.73 | PARP1 (0.56) | PDK2PARP1SCN9AKDM4EALDH1A1 | |
| SCHEMBL4776516 | 0.71 | PARP1 (0.52) | PDK2PARP1SCN9AALDH1A1HPGD |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20210275549-A1 | NOVEL FORMULATIONS | AEROMICS, INC. (US) | 2021-09-09 | — | — | US | disclosed |
| CN-112402434-A | New formula | 埃罗米克斯公司 | 2021-02-26 | — | — | CN | disclosed |
| CN-112370456-A | New formula | 埃罗米克斯公司 | 2021-02-19 | — | — | CN | disclosed |
| US-10894055-B2 | Pharmaceutical compositions, methods of making pharmaceutical compositions, and kits comprising 2-{[3,5-bis(trifluoromethyl)phenyl]carbamoyl}4-chlorophenyl dihydrogen phosphate | AEROMICS, INC. (US) | 2021-01-19 | — | — | US | disclosed |
| US-20190307779-A1 | NOVEL FORMULATIONS | AEROMICS, INC. (US) | 2019-10-10 | — | — | US | disclosed |
| EP-3454846-A1 | CRYSTALS | Aeromics, Inc. (US) | 2019-03-20 | — | — | EP | disclosed |
| WO-2017197371-A1 | CRYSTALS | AEROMICS, INC. (US) | 2017-11-16 | — | — | WO | disclosed |
| US-20160279155-A1 | NOVEL FORMULATIONS | AEROMICS, INC. (US) | 2016-09-29 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20210275549-A1 | NOVEL FORMULATIONS | DCPS, PRCP, DCTPP1 | STK10 4042/4885SLK 3745/4885PDK2 922/4885 |
| US-20190307779-A1 | NOVEL FORMULATIONS | DCPS, PRCP, DCTPP1 | STK10 4042/4885SLK 3745/4885PDK2 922/4885 |
| US-20160279155-A1 | NOVEL FORMULATIONS | AQP1, AQP4, AQP3 | STK10 3060/4885SLK 3442/4885PDK2 1366/4885 |
| US-10894055-B2 | Pharmaceutical compositions, methods of making pharmaceutical compositions, and kits comprising 2-{[3,5-bis(trifluoromethyl)phenyl]carbamoyl}4-chlorophenyl dihydrogen phosphate | PLCG2, DCPS, DCTPP1 | STK10 3370/4885SLK 2630/4885PDK2 676/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.